Ascelia Pharma AB (publ) (ACE.ST)
SEK 3.1
(-2.36%)
SEK 3.1
(-2.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 1.04 Million | 3.89 Million | 8.72 Million | 825 Thousand | 62 Thousand | 2.5 Million |
| Gross Profit | -1.04 Million | -3.89 Million | -8.72 Million | -825 Thousand | -62 Thousand | -2.5 Million |
| Operating Expenses | 110.91 Million | 143.77 Million | 129.17 Million | 93.25 Million | 36.68 Million | 34.62 Million |
| Selling, General and Administrative Expenses | 30.21 Million | 25.65 Million | 22 Million | 19.11 Million | 8.31 Million | 6.58 Million |
| Research and Development Expenses | 81.26 Million | 88.23 Million | 75.07 Million | 64.76 Million | 26.92 Million | 15.57 Million |
| Other Expenses | -564 Thousand | 29.88 Million | 32.09 Million | 9.37 Million | -1.44 Million | 12.45 Million |
| Cost and Expenses | 110.91 Million | 147.67 Million | 137.89 Million | 93.25 Million | 36.74 Million | 37.12 Million |
| Operating Income | -110.91 Million | -147 Million | -137.94 Million | -93.42 Million | -36.74 Million | -37.39 Million |
| Interest Expense | 2.41 Million | 48 Thousand | 77 Thousand | 13 Thousand | - | 33 Thousand |
| Income Tax Expense | -319 Thousand | -1.93 Million | -3.62 Million | -1.05 Million | -90 Thousand | -417 Thousand |
| Earnings before Tax | -109.6 Million | -133.15 Million | -129.52 Million | -99.74 Million | -39.99 Million | -37.55 Million |
| Net Income | -109.28 Million | -131.22 Million | -125.9 Million | -98.69 Million | -39.9 Million | -37.13 Million |
| Earnings Per Share Basic | -3.24 | -3.90 | -3.82 | -3.76 | -1.83 | -2.16 |
| Earnings Per Share Diluted | -3.24 | -3.90 | -3.82 | -3.76 | -1.83 | -2.16 |
| Weighted Average Shares Outstanding | 33.71 Million | 33.66 Million | 32.95 Million | 26.27 Million | 21.79 Million | 17.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.71 Million | 33.66 Million | 32.95 Million | 26.27 Million | 21.79 Million | 17.17 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -108.55 Million | -132.06 Million | -128.41 Million | -98.9 Million | -39.93 Million | -37.51 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | 1.04 Million | - | - | - |
| Gross Profit | - | - | -1.04 Million | - | - | - |
| Operating Expenses | 11.3 Million | 17.05 Million | 110.42 Million | 11.95 Million | 21.36 Million | 41.79 Million |
| Selling, General and Administrative Expenses | 4.53 Million | 6.22 Million | - | 5.47 Million | 7.51 Million | 10.94 Million |
| Research and Development Expenses | 7.48 Million | 10.81 Million | - | 6.48 Million | 13.95 Million | 31.21 Million |
| Other Expenses | 714 Thousand | -14 Thousand | -4.99 Million | 905 Thousand | -2.58 Million | -5.85 Million |
| Cost and Expenses | 11.3 Million | 17.05 Million | 111.47 Million | 11.95 Million | 21.36 Million | 41.79 Million |
| Operating Income | -11.3 Million | -17.05 Million | -111.47 Million | -11.95 Million | -21.36 Million | -41.79 Million |
| Interest Expense | 2.27 Million | 666 Thousand | 2.41 Million | -1.7 Million | 478 Thousand | 357 Thousand |
| Income Tax Expense | -2000.00 | -28 Thousand | -319 Thousand | -110 Thousand | -35 Thousand | -125 Thousand |
| Earnings before Tax | -13.27 Million | -16.72 Million | -109.6 Million | -10.7 Million | -21.25 Million | -40.37 Million |
| Net Income | -13.27 Million | -16.69 Million | -109.28 Million | -10.59 Million | -21.21 Million | -40.25 Million |
| Earnings Per Share Basic | -0.27 | -0.49 | - | -0.31 | -0.63 | -1.19 |
| Earnings Per Share Diluted | -0.27 | -0.49 | - | -0.31 | -0.63 | -1.19 |
| Weighted Average Shares Outstanding | 48.79 Million | 33.75 Million | 48.74 Million | 33.74 Million | 33.72 Million | 33.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.79 Million | 33.75 Million | 48.74 Million | 33.74 Million | 33.72 Million | 33.72 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -10.99 Million | -16.05 Million | - | -12.41 Million | -20.77 Million | -40.01 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
3E2
SENA
000957
OWUV
0639
GUNKUL